Junmin Quan

Title: Junmin Quan: Innovator in Pharmaceutical Composition Against SARS-CoV-2

Introduction

Junmin Quan is a notable inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the fight against COVID-19. His innovative work focuses on the use of a specific compound to inhibit the SARS-CoV-2 virus.

Latest Patents

Junmin Quan holds a patent for the "Use of Ovatodiolide against SARS-CoV-2." This patent describes a pharmaceutical composition that includes a safe and effective amount of Ovatodiolide, a compound that shows great potential in treating COVID-19. The formulation is designed to inhibit the virus effectively, providing a promising avenue for therapeutic intervention.

Career Highlights

Throughout his career, Junmin Quan has worked with prestigious institutions, including Peking University and Cns Biotek Corp. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.

Collaborations

Junmin has collaborated with esteemed colleagues such as Zhen Yang and Yew-Min Tzeng. These partnerships have contributed to the advancement of his research and the successful development of his patent.

Conclusion

Junmin Quan's work exemplifies the critical role of innovation in addressing global health challenges. His patent for Ovatodiolide represents a significant step forward in the fight against SARS-CoV-2, showcasing the importance of research and collaboration in the pharmaceutical industry.